Identification of a 16,600-dalton outer membrane protein on nontypeable Haemophilus influenzae as a target for human serum bactericidal antibody.
Open Access
- 1 October 1986
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 78 (4) , 1020-1027
- https://doi.org/10.1172/jci112656
Abstract
A 16,600-D outer membrane protein is present in all strains of Haemophilus influenzae and antibodies to this protein are present in human serum. This study was designed to assess the role of this outer membrane protein (P6) in nontypeable H. influenzae as a target for human serum bactericidal antibody. P6 was isolated and coupled to an affinity column. Depleting normal human serum of antibodies to P6 by affinity chromatography resulted in reduced bactericidal activity of that serum for nontypeable H. influenzae. Immunopurified antibodies to P6 from human serum were bactericidal. Finally, preincubation of bacteria with a monoclonal antibody that recognizes a surface epitope on P6, inhibited human serum bactericidal killing. Taken together, these experiments establish that P6 is a target for human bactericidal antibodies. This observation provides evidence that P6 plays a potentially important role in human immunity to infection by nontypeable H. influenzae.This publication has 30 references indexed in Scilit:
- Bactericidal Antibody Response of Normal Human Serum to the Lipooligosaccharide of Neisseria gonorrhoeaeThe Journal of Infectious Diseases, 1986
- Acute Maxillary Sinusitis in ChildrenNew England Journal of Medicine, 1981
- Outer Membrane Protein Composition in Disease Isolates of Haemophilus influenzae : Pathogenic and Epidemiological ImplicationsInfection and Immunity, 1980
- Bactericidal antibody and susceptibility to otitis media caused by nontypable strains of Haemophilus influenzaeThe Journal of Pediatrics, 1980
- Characterization of Gonococcal Antigens Responsible for Induction of Bactericidal Antibody in Disseminated InfectionJournal of Clinical Investigation, 1977
- HEMOPHILUS-INFLUENZAE TYPE-B CAPSULAR POLYSACCHARIDE VACCINE IN CHILDREN - DOUBLE-BLIND FIELD-STUDY OF 100,000 VACCINEES 3 MONTHS TO 5 YEARS OF AGE IN FINLAND1977
- Hemophilus influenzae, type b, antibody frequencies determined with bactericidal and radioimmunoassay tests.1976
- Sinusitis of the Maxillary AntrumNew England Journal of Medicine, 1975
- Human Serum Activities against Hemophilus influenzae, Type bJournal of Clinical Investigation, 1972
- HUMAN IMMUNITY TO THE MENINGOCOCCUSThe Journal of Experimental Medicine, 1969